These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 1955122

  • 1. Cisapride in children with chronic intestinal pseudoobstruction. An acute, double-blind, crossover, placebo-controlled trial.
    Di Lorenzo C, Reddy SN, Villanueva-Meyer J, Mena I, Martin S, Hyman PE.
    Gastroenterology; 1991 Dec; 101(6):1564-70. PubMed ID: 1955122
    [Abstract] [Full Text] [Related]

  • 2. Influence of cisapride on antroduodenal motor function in healthy subjects and diabetics with autonomic neuropathy.
    Wehrmann T, Lembcke B, Caspary WF.
    Aliment Pharmacol Ther; 1991 Dec; 5(6):599-608. PubMed ID: 1782304
    [Abstract] [Full Text] [Related]

  • 3. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.
    Camilleri M, Malagelada JR, Abell TL, Brown ML, Hench V, Zinsmeister AR.
    Gastroenterology; 1989 Mar; 96(3):704-12. PubMed ID: 2644150
    [Abstract] [Full Text] [Related]

  • 4. Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride.
    Fraser RJ, Horowitz M, Maddox AF, Dent J.
    Gut; 1994 Feb; 35(2):172-8. PubMed ID: 8307466
    [Abstract] [Full Text] [Related]

  • 5. Antroduodenal motility in children with chronic intestinal pseudo-obstruction.
    Hyman PE, McDiarmid SV, Napolitano J, Abrams CE, Tomomasa T.
    J Pediatr; 1988 Jun; 112(6):899-905. PubMed ID: 3373394
    [Abstract] [Full Text] [Related]

  • 6. The effect of cisapride and metoclopramide on human digestive and interdigestive antroduodenal motility.
    Lux G, Katschinski M, Ludwig S, Lederer P, Ellermann A, Domschke W.
    Scand J Gastroenterol; 1994 Dec; 29(12):1105-10. PubMed ID: 7886398
    [Abstract] [Full Text] [Related]

  • 7. Dual effects of cisapride on gastric emptying and antropyloroduodenal motility.
    Fraser R, Horowitz M, Maddox A, Dent J.
    Am J Physiol; 1993 Feb; 264(2 Pt 1):G195-201. PubMed ID: 8447401
    [Abstract] [Full Text] [Related]

  • 8. Absent postprandial duodenal motility in a child with cystic fibrosis. Correction of the symptoms and manometric abnormality with cisapride.
    Hyman PE.
    Gastroenterology; 1986 May; 90(5 Pt 1):1274-9. PubMed ID: 2870003
    [Abstract] [Full Text] [Related]

  • 9. The effects of cisapride on antroduodenal co-ordination and gastric emptying.
    Johnson AG.
    Scand J Gastroenterol Suppl; 1989 May; 165():36-43. PubMed ID: 2690323
    [Abstract] [Full Text] [Related]

  • 10. Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride.
    Camilleri M, Brown ML, Malagelada JR.
    Gastroenterology; 1986 Sep; 91(3):619-26. PubMed ID: 3525315
    [Abstract] [Full Text] [Related]

  • 11. Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction.
    Hyman PE, Di Lorenzo C, McAdams L, Flores AF, Tomomasa T, Garvey TQ.
    Am J Gastroenterol; 1993 Jun; 88(6):832-6. PubMed ID: 8503375
    [Abstract] [Full Text] [Related]

  • 12. Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease.
    Maddern GJ, Jamieson GG, Myers JC, Collins PJ.
    Gut; 1991 May; 32(5):470-4. PubMed ID: 2040466
    [Abstract] [Full Text] [Related]

  • 13. [Cisapride: pharmacology, current therapeutic results and future prospects].
    Fraitag B, Cloarec D, Galmiche JP.
    Gastroenterol Clin Biol; 1989 Mar; 13(3):265-76. PubMed ID: 2659417
    [No Abstract] [Full Text] [Related]

  • 14. Slow gastric emptying induced by high fat content of meal accelerated by cisapride administered rectally.
    Stacher G, Granser GV, Bergmann H, Kugi A, Stacher-Janotta G, Höbart J.
    Dig Dis Sci; 1991 Sep; 36(9):1259-65. PubMed ID: 1893810
    [Abstract] [Full Text] [Related]

  • 15. Cisapride in the treatment of chronic intestinal pseudo-obstruction.
    Reyntjens A, Verlinden M, Schuermans V.
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():79-84; discussion 92-3. PubMed ID: 2192509
    [No Abstract] [Full Text] [Related]

  • 16. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility.
    Abell TL, Camilleri M, DiMagno EP, Hench VS, Zinsmeister AR, Malagelada JR.
    Dig Dis Sci; 1991 May; 36(5):616-20. PubMed ID: 2022163
    [Abstract] [Full Text] [Related]

  • 17. Effect of cisapride on distal colonic motility in the early postoperative period following left colonic anastomosis.
    Roberts JP, Benson MJ, Rogers J, Deeks JJ, Wingate DL, Williams NS.
    Dis Colon Rectum; 1995 Feb; 38(2):139-45. PubMed ID: 7851167
    [Abstract] [Full Text] [Related]

  • 18. Effect of cisapride on gastric motility.
    Schuurkes J.
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():27-30; discussion 44. PubMed ID: 2356634
    [Abstract] [Full Text] [Related]

  • 19. Antroduodenal manometry in the evaluation of chronic functional gastrointestinal symptoms.
    Hyman PE, Napolitano JA, Diego A, Patel S, Flores AF, Grill BB, Reddy SN, Garvey TQ, Tomomasa T.
    Pediatrics; 1990 Jul; 86(1):39-44. PubMed ID: 2359682
    [Abstract] [Full Text] [Related]

  • 20. Changes in antroduodenal resistance induced by Cisapride in conscious dogs.
    Malbert CH, Serthelon JP, Dent J.
    Am J Physiol; 1992 Aug; 263(2 Pt 1):G202-8. PubMed ID: 1514631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.